Karista

Karista is an early-stage venture capital firm created in 2001. We funded 90+ companies over the past two decades and support tomorrow’s game changers in the field of Health, Digital, Tech, and NewSpace. We have always worked to provide more than cash and partnered with entrepreneurs whom we share a common vision with.

Tom Beauvironnet

Investment Manager

Catherine Boule

Managing Partner

Emmanuel Daugeras

Investment Director

Olivier Dubuisson

Managing Partner

Yvan-Michel Ehkirch

Managing Partner

Baudouin Hue

Partner

Michael Thomas

Senior Investment Manager

Benjamin Zerbib

Investment Director

Past deals in France

Exotrail

Series B in 2023
Exotrail SA, founded in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and their constellations. The company offers ExoMS, an innovative propulsion system designed to enable small satellite constellations to reach new orbits, and ExoOPS, a cloud-based software that aids engineers in designing and planning satellite missions. Exotrail's electric thrusters, specifically tailored for nano and micro-satellites, are utilized in various applications, including telecommunications, earth observation, and scientific research. The company's technology aims to create agile satellite constellations that enhance capabilities in these critical areas.

Ludocare

Seed Round in 2022
Ludocare focuses on developing therapeutic robots that assist patients with chronic diseases and their families. The company's innovative devices are designed to complement traditional drug treatments by providing personalized support that enhances treatment efficiency. By empowering patients, especially children, Ludocare aims to improve therapeutic compliance both quantitatively and qualitatively. This approach facilitates better disease management and helps stabilize essential treatments, ultimately contributing to improved autonomy and quality of life for patients and their families.

Leanspace

Seed Round in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Implicity

Series A in 2022
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.

Humanlinker

Seed Round in 2022
Shaping the future of revenue generation. Humanlinker is a cutting-edge AI guided technology for revenue generation teams

Sitowie

Seed Round in 2022
Sitowie is a company that specializes in developing software as a service (SaaS) technology aimed at understanding and managing the degradation of buildings. Utilizing artificial intelligence and machine learning, Sitowie's platform assists clients in anticipating risks associated with the aging of structures. The tools provided by the company not only enhance the sustainability of buildings but also contribute to cost reduction and facilitate effective arbitration processes. By focusing on the preservation and sustainability of heritage properties, Sitowie aims to support clients in making informed decisions regarding building maintenance and management.

Exotrail

Series A in 2020
Exotrail SA, founded in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and their constellations. The company offers ExoMS, an innovative propulsion system designed to enable small satellite constellations to reach new orbits, and ExoOPS, a cloud-based software that aids engineers in designing and planning satellite missions. Exotrail's electric thrusters, specifically tailored for nano and micro-satellites, are utilized in various applications, including telecommunications, earth observation, and scientific research. The company's technology aims to create agile satellite constellations that enhance capabilities in these critical areas.

Eyevensys

Series B in 2020
Eyevensys S.A.S. develops non-viral gene therapy treatments for ophthalmology. The company’s develops Electro-Transfection (ET) of plasmids to the ciliary muscle therapy to deliver calibrated and sustained therapeutic proteins preferentially in the vitreous for several months. It develops an Electro-Transfection Injection System (ETIS) which is a drug device solution consisting of a device and a pulse generator. The company focuses on Uveitis, age-related macular degeneration (AMD), and retinopathies, including Central Retinal Vein Occlusion (RVO) and Diabetic Retinopathy (DR/DME). Eyevensys S.A.S. was incorporated in 2008 and is based in Paris, France.

Tallano

Series A in 2019
Tallano Technologie manufactures particle collector that are present between the disc and the pad in private cars and public transport vehicles. The company offers tamic, a technology that traps the particles at source by suction. Tallano Technologie was incorporated in 2012 and is based in Boulogne-Billancourt, France.

UpFactor

Seed Round in 2019
UpFactor is an independent advisory firm based in Paris, France, specializing in the large-scale analysis of aerial land potential. Founded in 2017, the company utilizes a geographic information system that aggregates essential data for site analysis, including addresses, street widths, building heights, land use regulations, solar land registers, and protected areas. With a focus on providing comprehensive insights, UpFactor combines expertise in architecture, engineering, and law to assist clients in understanding the development potential of various sites.

TISSIUM

Series B in 2019
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Incepto Medical

Seed Round in 2019
Incepto Medical SAS develops and distributes artificial intelligence (AI) applications for medical imaging. The company’s products include Qure.ai qER, a software to help physicians in reading head CTs; Qure.ai qXR, a software to detect thorax abnormalities; Aidence Veye Chest for detecting, classifying, and tracking pulmonary nodules growth; Icometric Icobrain to monitor neurological disorders; and ScreenPoint Transpara to detect breast cancer. It also owns and operates Collective Minds Radiology, an online platform to get support on cases, share opinions, and learn from others. The company was founded in 2018 and is based in Paris, France.

Algaia

Acquisition in 2019
ALGAIA is a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed. ALGAIA offers a unique range of Natural and Sustainable products & solutions to the Agro-Nutrition, Personal Care and Pharmaceutical industries. Following the acquisition of Alganact SA, ALGAIA is also opening a Service Division for customers and partners willing to better understand the potential of their seaweed biomass or characterize their extracts.

Implicity

Seed Round in 2019
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.

Misakey

Seed Round in 2019
Misakey SAS designs and develops security software platform. The company offers an online platform that allows users to protect and manage their personal data across different social media platforms. It also enables webmasters to collaborate and integrate applications and create complaint websites. Misakey SAS was founded in 2018 and is based in Paris, France.

Admo.tv

Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Wisebatt

Seed Round in 2018
Wisebatt SAS, founded in 2016 and based in Chatou, France, specializes in web-based simulation software tailored for electronic engineers working on Internet of Things (IoT) devices. The platform allows users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing rapid access to complex modeling results that would typically take weeks, Wisebatt enhances the efficiency and effectiveness of hardware and software designers, as well as service providers. The technology is rooted in over 15 years of academic research, enabling users to make informed decisions regarding cost, battery life, and performance, ultimately leading to the development of more reliable and sustainable electronic solutions.

Tricares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Serious Factory

Series A in 2018
Serious Factory, founded in 2007 and based in Paris, France, specializes in developing training and sales support simulators that enhance customer relationships for various industries, including aerospace, automotive, banking, insurance, construction, energy, luxury, retail, distribution, medical, and telecommunications. The company offers a Software-as-a-Service solution known as the Virtual Training Suite, which complements and optimizes traditional training methods. With a focus on instructional engineering and gamification, Serious Factory provides a range of innovative learning solutions such as digital learning modules, Serious Games, and behavioral simulators, facilitating effective knowledge acquisition and skill development. The company's products are distributed through a network of partner resellers across Europe, Asia, and North America.

Appscho

Seed Round in 2018
AppScho, SAS is a Paris-based company founded in 2014 that specializes in developing mobile application software for the higher education sector. The application centralizes various intranet information, enabling students to easily access their schedules, grades, school events, and internship opportunities. It provides functionalities for students to preview upcoming courses, including classroom details and instructor information, while also sending notifications for any class changes. Additionally, the platform allows educational institutions and teachers to communicate with students, monitor engagement levels, and analyze academic performance. By streamlining access to essential information, AppScho aims to enhance student engagement and simplify communication within educational environments.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA engages in the research and development of lytic bacteriophages for therapeutic and diagnostic applications with a focus on antibiotic resistance. It develops several banks of bacteriophages, including the collection of phages against Escherichia coli. The company was incorporated in 2006 and is based in Romainville, France.

Acticor Biotech

Series A in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Precogs

Venture Round in 2017
Precogs is a company specializing in business analytics solutions, focusing on the electronic components sector. Founded in 2011 and based in Paris, France, Precogs provides tools for supply risk management, enterprise resource planning (ERP), and procurement monitoring. Their key products include CogWatch, a big data predictive tool designed to enhance decision-making, and Cog Margin, a platform that aids in component pricing. The company primarily assists EMS, OEM, and ODM businesses in sourcing competitive prices for electronic components in real-time, thereby streamlining procurement processes and optimizing cost-efficiency.

PayinTech

Venture Round in 2017
PayinTech SAS develops and provides cashless payment solutions using NFC technology. The company designs and integrates systems integrating private monetary payment, management, statistics, inventory and CRM on premises in "closed-loop". PayinTech SAS was founded in 2010 and is based in Paris, France.

Acticor Biotech

Seed Round in 2017
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Ugloo

Venture Round in 2017
Ugloo, offers an indestructible data storage solution. This secondary storage solution allows you to upgrade the available space in the infrastructure as a virtual rack. Since Ugloo reuses the available space in the infrastructure, the company does not need additional investments and retains 100% governance over its data.

Nexdot

Venture Round in 2016
Nexdot SAS develops, manufactures, and applies semiconductor nanocrystals of controlled size and shape called Quantum Dots. The company was incorporated in 2016 and is based in Romainville, France.

Restlet

Convertible Note in 2016
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Tricares

Seed Round in 2016
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Linkfluence

Series C in 2016
Linkfluence is a social media intelligence company that focuses on analyzing online conversations across various platforms, including social networks, blogs, and forums, to create business opportunities for brands. Its flagship product, the Radarly Product Suite, is a user-friendly, multilingual software-as-a-service solution designed to monitor, measure, and engage with social media content effectively. Radarly aids in reputation management, influencer engagement, community management evaluation, crisis detection, and best practice identification. Linkfluence also supports companies in customizing the tool to meet specific needs such as performance analysis, brand perception audits, and trend research. With over 200 prominent clients in Europe, Linkfluence empowers organizations to enhance their social strategies by leveraging social data intelligence. The company is backed by several venture capital firms, indicating strong investor confidence in its innovative approach to social media analysis.

NAVYA

Series B in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Stootie

Series A in 2016
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.

Playtem

Venture Round in 2016
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.

Comiteo

Venture Round in 2016
Comitéo, founded in 2008, designs and innovative services adapted to works councils. Comitéo supports a simple idea: to facilitate the mission of the elected by offering a web platform and mobile application, highly configurable for access to technology, culture, recreation, management and communication.

Nexdot

Venture Round in 2016
Nexdot SAS develops, manufactures, and applies semiconductor nanocrystals of controlled size and shape called Quantum Dots. The company was incorporated in 2016 and is based in Romainville, France.

Restlet

Convertible Note in 2016
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Bnbsitter

Series A in 2016
Bnbsitter allows vacation rental hosts to book welcome services for their guests. Guests’ check-in/check-out and rental cleaning are booked in less than two minutes. Busy at work, away for vacations or unable to meet arriving guests, Bnbsitter helps hosts to greet and welcome their guests with a smile!

TISSIUM

Series A in 2016
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Melusyn

Seed Round in 2016
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

NAVYA

Venture Round in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Restlet

Convertible Note in 2015
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

MOPeasy

Venture Round in 2015
MOPeasy, ecomobility operator, provides solutions for car sharing of electric vehicules and others, car pooling and access and reservations for charging stations, all in one platform. THE community solution adapted to companies, cities and collective habitats. MOPeasy turns charging stations into mobility stations, operates from 1 to 50 vehicules fleet for a Company. and from 1 station in Rural Communities up to 100 stations across a territory. Interoperable, MOPeasy's platform brings ecomobility solutions for Smart cities.

NAVYA

Seed Round in 2015
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Mitricares

Seed Round in 2015
MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.

Aterovax

Seed Round in 2015
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

Tricares

Seed Round in 2015
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Prestodiag

Series A in 2015
Prestodiag develops, manufactures and sells innovative solutions for rapid detection of bacteria. Their analytical solutions are based on an innovative optics technology called Surface Plasmon Resonance imaging and allow detection and identification of pathogenic bacteria such as Salmonella, Listeria or E.coli. They provide users with a result in just a few hours instead of 1 to several days. Their market is primarily the food safety sector, and also on medical and environmental applications.

Eyevensys

Seed Round in 2015
Eyevensys S.A.S. develops non-viral gene therapy treatments for ophthalmology. The company’s develops Electro-Transfection (ET) of plasmids to the ciliary muscle therapy to deliver calibrated and sustained therapeutic proteins preferentially in the vitreous for several months. It develops an Electro-Transfection Injection System (ETIS) which is a drug device solution consisting of a device and a pulse generator. The company focuses on Uveitis, age-related macular degeneration (AMD), and retinopathies, including Central Retinal Vein Occlusion (RVO) and Diabetic Retinopathy (DR/DME). Eyevensys S.A.S. was incorporated in 2008 and is based in Paris, France.

Melusyn

Seed Round in 2015
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

Red Technologies

Seed Round in 2015
RED Technologies’ end to end dynamic spectrum sharing solutions have the potential to radically and rapidly secure further wireless market growth worldwide, supporting positive change at many levels of our economy and society.

Serious Factory

Seed Round in 2015
Serious Factory, founded in 2007 and based in Paris, France, specializes in developing training and sales support simulators that enhance customer relationships for various industries, including aerospace, automotive, banking, insurance, construction, energy, luxury, retail, distribution, medical, and telecommunications. The company offers a Software-as-a-Service solution known as the Virtual Training Suite, which complements and optimizes traditional training methods. With a focus on instructional engineering and gamification, Serious Factory provides a range of innovative learning solutions such as digital learning modules, Serious Games, and behavioral simulators, facilitating effective knowledge acquisition and skill development. The company's products are distributed through a network of partner resellers across Europe, Asia, and North America.

English Attack

Series A in 2015
Entertainment Learning SAS operates English Attack, an online English language learning platform for independent teachers, schools, universities, language institutes, and companies in Greece and Cyprus. It offers video exercises based on movies, TV series, music, and current events; visual dictionaries on various topics; a range of language games that allow users to review vocabulary items, practice irregular verbs, and fine-tune oral comprehension; and private English lessons. The company offers its service as a subscription service direct to consumers; via multi-user licenses to schools, language institutes, universities, and other educational institutions; and company language training programs. Entertainment Learning SAS was founded in 2009 and is based in Paris, France.

VitamFero

Series C in 2015
VitamFero SA, a biotechnology company, designs, develops, registers, and markets prophylactic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO. It offers vaccines, such as VFOtx-251, VFOne-273 and VFOlh-211 for the treatment of ovine toxoplasmosis, bovine neosporosis, canine leishmaniasis, and equine protozoal myeloencephalitis (EPM) respectively. The company was founded in 2005 and is based in Angers, France.

PayinTech

Seed Round in 2015
PayinTech SAS develops and provides cashless payment solutions using NFC technology. The company designs and integrates systems integrating private monetary payment, management, statistics, inventory and CRM on premises in "closed-loop". PayinTech SAS was founded in 2010 and is based in Paris, France.

Stootie

Seed Round in 2015
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.

Open Ocean

Seed Round in 2015
Open Ocean is an innovative company based in Brest and Paris, which conceives since 2011 online decision-making solutions for industrial marine activities. Their highly qualified team of oceanographers, trained in the best research oceanographic institutes of the world (UPMC, IFREMER, University of Washington) is specialized in high resolution modelling, statistical analysis and data mining.

Pherecydes Pharma

Series A in 2014
Pherecydes Pharma SA engages in the research and development of lytic bacteriophages for therapeutic and diagnostic applications with a focus on antibiotic resistance. It develops several banks of bacteriophages, including the collection of phages against Escherichia coli. The company was incorporated in 2006 and is based in Romainville, France.

Restlet

Convertible Note in 2014
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Web Geo Services

Seed Round in 2014
Web Geo Services SAS, founded in 2009 and headquartered in Montpellier, France, specializes in online mapping and geolocation applications. The company provides location-based software as a service (SaaS) technology tailored for various industries, including retail, e-commerce, travel, hospitality, banking, and automotive. By leveraging Google Maps, Web Geo Services assists businesses in enhancing customer engagement and driving conversions through effective digital systems. The company has established itself as a leading partner of Google Cloud in Europe and has successfully collaborated with more than 400 large companies. Its flagship product, Woosmap, is recognized for enabling developers to integrate advanced location intelligence features into mobile applications and websites. Web Geo Services focuses on delivering innovative solutions that empower clients to optimize online customer journeys and boost revenue.

Playtem

Venture Round in 2014
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.

Precogs

Seed Round in 2014
Precogs is a company specializing in business analytics solutions, focusing on the electronic components sector. Founded in 2011 and based in Paris, France, Precogs provides tools for supply risk management, enterprise resource planning (ERP), and procurement monitoring. Their key products include CogWatch, a big data predictive tool designed to enhance decision-making, and Cog Margin, a platform that aids in component pricing. The company primarily assists EMS, OEM, and ODM businesses in sourcing competitive prices for electronic components in real-time, thereby streamlining procurement processes and optimizing cost-efficiency.

Rool'in

Seed Round in 2014
Rool'in offers innovative, practical and ecological solutions in the field of bicycle mobility.

Neelogy

Seed Round in 2013
Neelogy develops and markets non-remanence magnetic sensors (thus very precise and non-intrusive) for the measurement of alternating and continuous electrical currents. The company's mission: to meet new needs related to energy metering, AC / DC energy conversion, electrical energy storage, real-time fault detection and diagnostics.

Axess Vision Technology

Series B in 2013
Axess Vision Technology S.A. designs disposable sterile endoscopes. It offers bronchoscopy, urology, animal health, and other interface products. The company was founded in 2006 and is based in Saint-Pierre-des-Corps, France.

TISSIUM

Series A in 2013
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Aterovax

Seed Round in 2013
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

Restlet

Seed Round in 2013
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

AlephD

Series A in 2013
AlephD SAS provides publishers with real-time optimization strategies together with business intelligence solutions. It offers YieldEngine, a real-time yield management solution for AppNexus; InstantPredict, which addresses publishers’ constant need to decide what source of revenue to prioritize; and InventoryLab, an integrated software suite to help publishers to make decisions based on data analysis and business intelligence tools. The company was incorporated in 2012 and is based in Paris, France. As of January 25, 2016, AlephD SAS operates as a subsidiary of AOL Inc.

Fidzup

Seed Round in 2013
Fidzup provides web oriented tools to brick & mortar businesses. The company has created a unique instore analytics platform that allows retailers to retarget their customers with personalized ads on mobile. The company was incorporated in 2013 and is based in Paris, France.

Fidzup

Angel Round in 2013
Fidzup provides web oriented tools to brick & mortar businesses. The company has created a unique instore analytics platform that allows retailers to retarget their customers with personalized ads on mobile. The company was incorporated in 2013 and is based in Paris, France.

Nanoe

Seed Round in 2013
Nanoe Sarl develops ready-to-sinter nanopowders for the ceramic industry. It offers ready-to-press granulates, slurries, raw materials, and tailor-made solutions. The company was founded in 2008 and is based in Chilly-Mazarin, France.

e(ye)BRAIN

Series B in 2012
e(ye)BRAIN is a medical company that manufactures and distributes eye trackers for its clients. e(ye)BRAIN’s range of products include Eye Brain T1 and T2. The T1 enables its users to record eye movements. T2 uses algorithms to enable its users to record eye and head movements. The recorded movements will be analyzed by a software called MeyeEval. The company offers advisory, paradigm development, formation, and support services to its clients. e(ye)BRAIN was founded in 2008 by Serge Kinkingnehun and is based in France.

WeCook WeCare

Seed Round in 2012
WeCook is the new companion for a better nutrition and a better health. It uses his meal planner and the Alantaya's technology in order to offer the best high personnalized nutritionnal recommandation and the best coaching with dieteticians. High personnalized nutritionnal recommandation goes from Cancer to pregnancy.

Plasmabiotics

Seed Round in 2012
SAS PlasmaBiotics operates as a biotechnology company that designs, manufactures and markets generators of cold plasma nitrogen for medical disinfection. The company was incorporated in 2011 and is based in Evry, France. As of August 1, 2018, SAS PlasmaBiotics operates as a subsidiary of HOYA Corporation.

Green Point SAS

Seed Round in 2012
GreenPoint specialises in regtech, namely in digital and mobile management of know your customer (KYC), digital processing of customers’ records and customer on-boarding.

Plasmabiotics

Acquisition in 2012
SAS PlasmaBiotics operates as a biotechnology company that designs, manufactures and markets generators of cold plasma nitrogen for medical disinfection. The company was incorporated in 2011 and is based in Evry, France. As of August 1, 2018, SAS PlasmaBiotics operates as a subsidiary of HOYA Corporation.

VitamFero

Seed Round in 2011
VitamFero SA, a biotechnology company, designs, develops, registers, and markets prophylactic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO. It offers vaccines, such as VFOtx-251, VFOne-273 and VFOlh-211 for the treatment of ovine toxoplasmosis, bovine neosporosis, canine leishmaniasis, and equine protozoal myeloencephalitis (EPM) respectively. The company was founded in 2005 and is based in Angers, France.

EVIAGENICS

Series A in 2011
EVIAGENICS is a biotechnology company generating new products and improved manufacturing processes for the chemical and pharmaceutical industry by applying its unique in vivo recombination technology. After the successful validation of the technology in several collaborations with industrial partners from red and white biotechnology EVIAGENICS will focus its activities on the development of a technology platform for the efficient recombination and expression of metabolic pathways in cells. These reprogrammed cells will be able to transform sugars from cheap renewable sources like feedstock into numerous new high value compounds.

Edenwall Technologies

Seed Round in 2010
Edenwall is a security vendor of identity-based firewall connection filtering solutions.

Physikron

Seed Round in 2010
Physikron is a developer of mass spectrometry technologies used to improve the performance of tandem spectrometry. Its technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during an LC/MS/MS acquisition that enable researchers to research in an enhanced way.

Algaia

Seed Round in 2010
ALGAIA is a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed. ALGAIA offers a unique range of Natural and Sustainable products & solutions to the Agro-Nutrition, Personal Care and Pharmaceutical industries. Following the acquisition of Alganact SA, ALGAIA is also opening a Service Division for customers and partners willing to better understand the potential of their seaweed biomass or characterize their extracts.

Nanobiotix

Series C in 2010
Nanobiotix SA operates as a clinical-stage nanomedicine company for the treatment of cancer worldwide. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a radio-enhancer hafnium oxide for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, and other cancers. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France.

e(ye)BRAIN

Series A in 2009
e(ye)BRAIN is a medical company that manufactures and distributes eye trackers for its clients. e(ye)BRAIN’s range of products include Eye Brain T1 and T2. The T1 enables its users to record eye movements. T2 uses algorithms to enable its users to record eye and head movements. The recorded movements will be analyzed by a software called MeyeEval. The company offers advisory, paradigm development, formation, and support services to its clients. e(ye)BRAIN was founded in 2008 by Serge Kinkingnehun and is based in France.

Neelogy

Acquisition in 2009
Neelogy develops and markets non-remanence magnetic sensors (thus very precise and non-intrusive) for the measurement of alternating and continuous electrical currents. The company's mission: to meet new needs related to energy metering, AC / DC energy conversion, electrical energy storage, real-time fault detection and diagnostics.

InnaVirVax

Series A in 2009
InnaVirVax is a privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and new cancer therapies.

Up & Net

Series B in 2009
Up&Net SAS develops gift card solutions used on ecommerce sites. The company also publishes Cadeaux-avenue.com, a gateway for gifts; and Monblogshopping.com, a platform of blogs dedicated to shopping. Up&Net SAS was incorporated in 2005 and is based in Paris, France.

Sesamea

Series A in 2008
Sesamea is a French company providing electronic gift and cash cards, redeemable at a number of stores and french retailers.

Advestigo

Series B in 2008
Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package that allows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.

Codasystem

Venture Round in 2008
Codasystem is a French start-up which offers a real time monitoring tool, using software that allows users to take digital photographs with a mobile telephone that can be used as legal proof.

WatchFrog

Series A in 2008
WatchFrog's versatile technology derives from a fundamental research program carried out within an internationally recognized research laboratory affiliated to the CNRS (National Research Council) and located within the French Natural History Museum. WatchFrog has been granted a 450.000 euros award from the French Ministry of Research for its innovative activity and technology.

Idylis

Series B in 2007
Idylis S.A. designs, develops, and markets software solutions for enterprise management. Its products assist in audit and accounting, financial management, documentation, e-mailing, and scheduling applications. The company also offers solutions for commercial applications such as supply chain management, logistics, and inventory management. In addition, it provides customer support and consulting services to its clients. The company was incorporated in 2008 and is based in Issy-les-Moulineaux, France.

Voluntis

Venture Round in 2007
Voluntis, Inc. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas. It offers Insulia, a prescription-only medical device that provides type 2 diabetes patients with insulin dose recommendations and educational coaching messages based on blood glucose values and other diabetes-related data; and Diabeo, a digital solution for type 1 and type 2 patients treated on a basal-bolus insulin regimen, which suggests insulin dosage, through algorithmic calculations that are specific to the patient and based on their particular doses. Voluntis, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.

erytech

Venture Round in 2006
ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.